Walker Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
UBP
Walker Asset Management's BMY Position: Q2 2026 in Review
Walker Asset Management increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, buying an estimated $5.4K and bringing the position to 8,616 shares worth $496K. The position accounts for 0.25% of the portfolio, ranked #77.
Walker Asset Management first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $517K in Q1 2026. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Walker Asset Management held 8,616 shares of Bristol-Myers Squibb worth $496K as of Q2 2026.
- Walker Asset Management bought 94 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.4K.
- Bristol-Myers Squibb made up 0.25% of Walker Asset Management's portfolio in Q2 2026, its #77 holding.
- Walker Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Walker Asset Management's Bristol-Myers Squibb position peaked at $517K in Q1 2026.
- 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Walker Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.